Prime Medicine, Inc. Common Stock (PRME) — Working Capital to Net Assets Ratio
Prime Medicine, Inc. Common Stock (PRME) has a Working Capital to Net Assets ratio of 163.6% as of June 2026. Working capital of $65.11 Million (current assets of $96.80 Million minus current liabilities of $31.69 Million) is measured against net assets of $39.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PRME defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Prime Medicine, Inc. Common Stock Working Capital to Net Assets (2019–2025)
This chart shows how Prime Medicine, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 163.6%, reflecting working capital of $65.11 Million against net assets of $39.81 Million USD. For the complete balance sheet picture, see Prime Medicine, Inc. Common Stock (PRME) total assets.
Annual Working Capital to Net Assets for Prime Medicine, Inc. Common Stock (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Prime Medicine, Inc. Common Stock from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PRME financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 119.0% | $143.84 Million | $120.87 Million | $181.29 Million | $37.45 Million | ▲ +5.4 pp |
| 2024 | 113.6% | $173.93 Million | $153.15 Million | $211.89 Million | $37.96 Million | ▲ +48.5 pp |
| 2023 | 65.0% | $86.55 Million | $133.07 Million | $142.98 Million | $56.42 Million | ▼ -20.3 pp |
| 2022 | 85.3% | $269.90 Million | $316.27 Million | $296.62 Million | $26.71 Million | ▼ -3.4 pp |
| 2021 | 88.7% | $212.60 Million | $239.56 Million | $270.58 Million | $57.98 Million | ▼ -12.7 pp |
| 2020 | 101.5% | $33.96 Million | $33.47 Million | $53.40 Million | $19.44 Million | ▲ +1.5 pp |
| 2019 | 100.0% | $1.39 Million | $1.39 Million | $8.70 Million | $7.31 Million | — |